Glancy Prongay & Murray LLP: Securities Fraud Class Action Lawsuit Against ModivCare, Inc.
On March 19, 2025, Glancy Prongay & Murray LLP, a leading national litigation law firm, announced that investors who have suffered losses on their ModivCare, Inc. (“ModivCare” or the “Company”) investments have the opportunity to lead the securities fraud class action lawsuit against the Company. The lawsuit alleges that ModivCare and certain of its executives violated the Securities Exchange Act of 1934 by making false and misleading statements and failing to disclose material information to the investing public.
Background of ModivCare, Inc.
ModivCare is a healthcare services company that provides post-acute care services to patients in their homes. The Company offers a range of services, including infusion therapy, home health, hospice care, and respiratory therapy. ModivCare’s business model is focused on delivering high-quality care in the home setting, which is becoming increasingly popular as the population ages and healthcare costs continue to rise.
The Allegations
The securities fraud class action lawsuit alleges that ModivCare and certain of its executives made false and misleading statements and failed to disclose material information to investors regarding the Company’s financial condition and business prospects. Specifically, the lawsuit alleges that the Company failed to disclose that its financial results were being negatively impacted by a decline in patient volumes and increased competition, among other issues.
The Impact on Investors
The impact of this securities fraud class action lawsuit on investors who purchased ModivCare securities prior to March 19, 2025, the date of the announcement, could be significant. These investors may be entitled to recover their losses through the class action lawsuit if they can prove that they relied on the false and misleading statements made by ModivCare and its executives when making their investment decisions. The lead plaintiff deadline to participate in the lawsuit is March 31, 2025.
The Impact on the World
The securities fraud class action lawsuit against ModivCare, Inc. is an important development in the world of securities litigation. It highlights the need for companies to provide transparent and accurate information to investors, and the potential consequences for those who fail to do so. The lawsuit may also serve as a warning to other healthcare services companies to ensure that they are providing accurate and complete information to investors regarding their financial condition and business prospects.
Conclusion
The securities fraud class action lawsuit against ModivCare, Inc. is an important development for investors who purchased the Company’s securities prior to March 19, 2025. If you believe that you have suffered losses as a result of the false and misleading statements made by ModivCare and its executives, you may be entitled to recover your losses through the class action lawsuit. The lead plaintiff deadline to participate in the lawsuit is March 31, 2025. This lawsuit serves as a reminder to all companies to provide transparent and accurate information to investors, and the potential consequences for those who fail to do so.
- Glancy Prongay & Murray LLP announces securities fraud class action lawsuit against ModivCare, Inc.
- Allegations include false and misleading statements and failure to disclose material information.
- Impact on investors: potential for recovery of losses through the class action lawsuit.
- Impact on the world: reminder for companies to provide transparent and accurate information to investors.
- Lead plaintiff deadline: March 31, 2025.
